Results-driven scientist with a robust background in research and development, specializing in data analysis, experimental design, and advanced laboratory techniques. Six years of experience at Patheon Pharmaceuticals as an R&D Scientist II, contributing to Pharmaceutical Development Services within a cGMP/cGLP controlled environment. Proven ability to adapt to evolving project needs while fostering team collaboration to deliver impactful solutions. A solid foundation in biotechnology, complemented by extensive experience in corporate operations and management, enhances the capability to bridge scientific expertise with strategic business insights.
1st Analyst, Assay and Impurities testing for MK-4482 (Molnupiravir) and accepting responsibility for timely testing of continuing lots.
Supported testing for a 2nd reputable pharmaceutical company, testing lead lead to manufacturing of a broader spectrum drug effective against SARS-CoV-2 and other more diminished variants.